Related Experiment Video
Updated: Oct 4, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Designing an App for Immunosuppression Adherence and Communication: A Qualitative Approach
Kara Schick-Makaroff1, Laura Lagendyk2, Bethany Foster3,4
1University of Alberta, Edmonton, Canada.
Background:
Immunosuppression nonadherence may be the most important factor limiting long-term allograft survival.
Objective:
Following user-centered design, we explored the essential priorities and preferences of kidney transplant recipients and healthcare providers (HCP) to inform development of a smartphone app to improve immunosuppression adherence and communication.
Design:
A qualitative descriptive research design was used.
Setting:
The University of Alberta Hospital adult kidney transplant program in Edmonton, Canada.
Participants:
Participants were recruited by convenience sampling and included 32 kidney transplant recipients and 11 HCPs.
Methods:
Seven focus groups (5 with recipients and 2 with HCPs) were conducted to inform app development. Sessions were recorded, and transcripts were coded to elucidate themes.
Results:
App development to improve adherence was not a priority for HCP. Recipients prioritized choice: that all features be optional. Recipients preferred support while traveling; access to laboratory results; and use by younger or newly transplanted recipients. Both recipients and HCP preferred linkage to pharmacy; and self-management and accountability.For the app to improve communication, HCPs believed the priorities to be addressed included: clarity on scope of app; legal, ethical, and professional obligations; and charting. Both recipients and HCP prioritized HCP workload, and broader medication and health concerns. Healthcare providers preferred tech support; both recipients and HCPs preferred app access for nontransplant HCP.
Limitations:
Limitations include underrepresentation of physicians, recipients with racial/ethnic diversity, and potential selection bias of transplant recipients who perceived themselves to be adhering to immunosuppression medications.
Conclusion:
Future research is needed for the app to become a comprehensive, secure platform for broader communication between recipients and HCP, pharmacies, and nontransplant clinicians while streamlining HCP workload.
Related Concept Videos
Dosage Regimens: Designs and Approaches
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Kidney Transplant III: Nursing Management
Role of Communication in the Nursing Process II: Planning and Implementation
Bioavailability Study Design: Healthy Subjects Versus Patients
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

